-
Healthy Hearts and Healthy Wallets: Why one HealthTech Startup is a Must-Invest
Previously published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Last month, we saw a lot of great startups at the Benzinga Global Small Cap Conference. Many of them screamed, “This is an innovation tech stock you need to buy now!” But given the state of our world at this moment, one startup really stood out. Its key product is the Bioflux and it’s considered the “smallest, most accurate device on the market.” Our Current Problem Heart disease is the leading cause of death in men and women every year in the United States.…
You May Also Like
See-Through Technology Features New Possibilities
Vision in Sight — Vuzix Outlines Ultra-Sleek Lineup of Smart Glasses, CES 2022 Presence, and Partnerships
An Empire For Solar Discovery And Education In The Making? SinglePoint Reports Building Out Network For Clean Air And Green Energy Efficiency
-
Keep Your New Year’s Resolution with the Good Habit App
Previously Published to TalentZoo’s Digital Pivot With New Year’s on the way, everyone is making resolutions to stop procrastinating or to stop biting their nails or to quit smoking. Truthfully, everyone is making some type of resolution, but not many will actually keep them. There are a few reasons for this. One reason may be that they didn’t practice before the New Year — when they knew they would backslide, giving up once the year begins due to discouragement. Another reason may be that they actually couldn’t handle the pressure. But, for the most part, people just plain forget. Habits come to us as second nature, so there is no way…
-
Evariant Awarded Funding to Innovate Healthcare CRM
Previously Published to TMC Net’s HealthTech Zone Evariant, which offers an end-to-end CRM solution, has announced it received $42.3M in Series C financing through financial institution, Goldman Sachs, which will be used toward innovations in their current CRM healthcare platform for providers. The company also said it secured both Series A and B leads in Health Enterprise Partners and Lightspeed Venture Partners, who have raised additional funding on behalf of the brand. With over $70M in funding, the startup plans to focus on growth and evolution of their platform, starting with service lines, engineering and customer success teams. Recently opening a fourth office in Austin, this capital will allow Evariant…
